PRIMVIXLA
DEAD

Serial Number

79233958

Owner

NOVARTIS AG

Filing Date

Mar 22, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PRIMVIXLA Trademark

Serial Number: 79233958 • Registration: 5577858

PRIMVIXLA is a trademark filed by NOVARTIS AG on March 22, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

March 22, 2018

Registration Date

October 9, 2018

Published for Opposition

July 24, 2018

Cancellation Date

August 7, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Aug 28, 2025 DETH
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Aug 18, 2025 CORN
CANCELLED SECTION 71
Apr 25, 2025 C71T
CORRECTION TRANSACTION RECEIVED FROM IB
Dec 20, 2018 CRCV
NOTIFICATION PROCESSED BY IB
Dec 7, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Nov 18, 2018 FICS
FINAL DISPOSITION PROCESSED
Nov 18, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Nov 8, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Oct 9, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jul 24, 2018 PUBO
NOTICE OF PUBLICATION
Jul 4, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 19, 2018 CNSA
ASSIGNED TO EXAMINER
Jun 19, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jun 16, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 12, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 11, 2018 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Jun 7, 2018 SDRC